Oral Abstract Session:
278. Pneumococcal and Pertussis Vaccines
Saturday, October 7, 2017: 2:00 PM-3:30 PM
Room: 08

Tracks: Pediatric ID


Moderators:  Kathryn Edwards, MD, FIDSA, Vanderbilt University School of Medicine and Elaine Tuomanen, MD, St. Jude Children's Research Hospital

Presentations:
2:00 PM
Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
Tamara Pilishvili, MPH, PhD; Ryan Gierke, MPH; Monica Farley, MD, FIDSA; William Schaffner, MD, FIDSA, FSHEA; Ann Thomas, MD, MPH; Arthur Reingold, MD, FIDSA; Lee Harrison, MD; Ruth Lynfield, MD, FIDSA; Shelley M. Zansky, PhD; Susan Petit, MPH; Lisa Miller, MD, MSPH; Joan Baumbach, MD, MPH, MS; Bernard Beall, PhD; Cynthia Whitney, MD, MPH, FIDSA
2:15 PM
Invasive pneumococcal disease in Massachusetts children six years following introduction of PCV13
Inci Yildirim, MD PhD MSc; Brent Little, PhD; Stephen I. Pelton, MD
2:30 PM
Analysis of Invasive Pneumococcal Infections Due to 13-Pneumococcal Conjugate Vaccine Serotypes at 8 US Children's Hospitals During 2014 to 2016
Sheldon L. Kaplan, MD, FIDSA; William J. Barson, MD, FPIDS; Philana Ling Lin, MD; Jose R. Romero, MD; John S. Bradley, MD, FIDSA, FPIDS, FAAP; Tina Tan, MD, FIDSA; Laurence B. Givner, MD; Jill Hoffman, MD; Kristina Hulten, PhD; Edward O. Mason Jr., PhD, FIDSA
2:45 PM
Changes in Pneumonia Incidence and Infant Mortality 5 Years Following Introduction of the 13-valent Pneumococcal Conjugate Vaccine in a “3+0” Schedule in Nicaragua
Sylvia Becker-Dreps, MD, MPH; Bryan Blette, BS; Rafaela Briceno, MD; Jorge Aleman, MD; Michael G. Hudgens, PhD; Gilberto Moreno, MD, MPH; Ana Ordonez, RN; Julio Rocha, RN, MPH; David J. Weber, MD, MPH, FIDSA, FSHEA; Erick Amaya, PhD
3:00 PM
A population-based study of recurrent symptomatic Bordetella pertussis infections in children in California, 2010-2015
Lauren Platt, BA; Melissa Thun, RN, BSN; Kathleen Harriman, PhD, MPH, RN; Kathleen Winter, MPH, PhD
3:15 PM
Effectiveness of prenatal Tdap immunization in the prevention of infant pertussis in the US
Sylvia Becker-Dreps, MD, MPH; Anne M. Butler, PhD; Leah J. McGrath, PhD; Kim A. Boggess, MD; David J. Weber, MD, MPH; Dongmei Li, MS; Michael G. Hudgens, PhD; J. Bradley Layton, PhD

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.